✦ LIBER ✦

Efficacy of Memantine by Baseline Disease Severity: Post-hoc Analysis of Pooled Trials in Patients with Mild to Moderate Alzheimer's Disease

✍ Scribed by Tocco, Michael; Tocco, Michael; Hendrix, Suzanne; Miller, Michael L.; Pejovic, Vojislav; Graham, Stephen M.

Book ID: 123527959
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 12
Category: Article
ISSN: 1538-9375
DOI: 10.1016/j.jamda.2010.12.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in behavioural symptoms in p

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

✍ S. Gauthier; H. Loft; J. Cummings 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Introduction Behavioural disturbances are a common and distressing aspect of Alzheimer's disease (AD). This pooled analysis evaluated the specific benefits of memantine on behavioural disturbances in patients with moderate to severe AD. ## Methods Data were pooled from six 24/28‐w

Efficacy of high-dose, extended-release

Efficacy of high-dose, extended-release memantine (28 mg, once daily): Post hoc responder analysis from a randomized trial in patients with moderate to severe Alzheimer's disease

✍ Graham, Stephen; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Tocco, Mi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Efficacy of memantine in people with mod

Efficacy of memantine in people with moderate to severe Alzheimer's disease with and without background donepezil therapy: Pooled analysis of four randomized trials

✍ Graham, Stephen; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Tocco, Mi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Commentary on “Meta-analysis of six-mont

Commentary on “Meta-analysis of six-month memantine trials in Alzheimer’s disease.” Memantine has negligible benefits in mild to moderate Alzheimer’s disease

✍ David S. Knopman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Effects of extended-release memantine (2

Effects of extended-release memantine (28 mg/day) on cognitive domains in patients with moderate to severe Alzheimer's disease: Post hoc analysis of a randomized trial

✍ Tocco, Michael; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Graham, St 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB

P4-329: Post HOC responder analyses of M

P4-329: Post HOC responder analyses of Memantine treatment on behavioral disturbances in patients with moderate to severe Alzheimer's disease

✍ Stender, Karina; Cummings, Jeffrey 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB